Tenon Medical, Inc. (TNON)

Market Cap	7.48M
Revenue (ttm)	3.28M
Net Income (ttm)	-13.71M
Shares Out	7.59M
EPS (ttm)	-6.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,294
Open	0.9709
Previous Close	0.9802
Day's Range	0.9650 - 0.9996
52-Week Range	0.8500 - 15.7880
Beta	1.22
Analysts	Strong Buy
Price Target	11.67 (+1,084.17%)
Earnings Date	Aug 12, 2025

About TNON

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 27, 2022
• Employees: 27
• Stock Exchange: NASDAQ
• Ticker Symbol: TNON
• Website: https://www.tenonmed.com

Financial Performance

In 2024, Tenon Medical's revenue was $3.28 million, an increase of 11.92% compared to the previous year's $2.93 million. Losses were -$13.67 million, -12.25% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for TNON stock is "Strong Buy." The 12-month stock price target is $11.67, which is an increase of 1,084.17% from the latest price.

Price Target

$11.67

(1,084.17% upside)

Analyst Consensus: Strong Buy